Načítá se...
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
AIMS/HYPOTHESIS: Oral administration of antigen can induce immunological tolerance. Insulin is a key autoantigen in childhood type 1 diabetes. Here, oral insulin was given as antigen-specific immunotherapy before the onset of autoimmunity in children from age 6 months to assess its safety and immune...
Uloženo v:
| Vydáno v: | Diabetologia |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8012335/ https://ncbi.nlm.nih.gov/pubmed/33515070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-020-05376-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|